Gefitinib usage and outcomes in routine treatment
Study identifier:NIS-OGB-IRE-2012/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A multicentre, retrospective chart review study to characterise gefitinib usage and outcomes in routine treatment
Medical condition
lung cancer
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
157
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jun 2013
Primary Completion Date: 01 Nov 2013
Study Completion Date: 01 Nov 2013
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Oct 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Gefitinib | - |
Contacts
Investigators
Principal Investigator
Fiona Blackhall
The Christie NHS Foundation Trust
